Search research articles
Contact Us
Filters
Showing results (191-200 of 254) with videos related to
Page
of 26
Sort By:
Journal of Crohn'S & Colitis
|
February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease
Marjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Therapeutic Advances in Gastroenterology
|
August 9, 2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
Bénédicte Caron, Philippe Seksik, Anthony Buisson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2017
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission
Catherine Reenaers, Jean-Yves Mary, Maria Nachury, et al.
United European Gastroenterology Journal
|
November 18, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's disease
Anthony Buisson, Emilie Vazeille, Mathurin Fumery, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurélien Amiot, Jérôme Filippi, Vered Abitbol, et al.
Alimentary Pharmacology & Therapeutics
|
July 23, 2021
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fumery, Jérôme Filippi, Vered Abitbol, et al.
Journal of Crohn'S & Colitis
|
January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
Antoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis
|
February 26, 2022
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective Cohort
Clément Julien, Emré Anakok, Xavier Treton, et al.
Journal of Crohn'S & Colitis
|
March 24, 2017
Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis
Mathieu Uzzan, Julien Kirchgesner, Nadia Oubaya, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 254) with videos related to
Sort By:
Page
of 26
Journal of Crohn'S & Colitis
|
February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease
Marjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Therapeutic Advances in Gastroenterology
|
August 9, 2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
Bénédicte Caron, Philippe Seksik, Anthony Buisson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2017
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission
Catherine Reenaers, Jean-Yves Mary, Maria Nachury, et al.
United European Gastroenterology Journal
|
November 18, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's disease
Anthony Buisson, Emilie Vazeille, Mathurin Fumery, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurélien Amiot, Jérôme Filippi, Vered Abitbol, et al.
Alimentary Pharmacology & Therapeutics
|
July 23, 2021
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fumery, Jérôme Filippi, Vered Abitbol, et al.
Journal of Crohn'S & Colitis
|
January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
Antoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis
|
February 26, 2022
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective Cohort
Clément Julien, Emré Anakok, Xavier Treton, et al.
Journal of Crohn'S & Colitis
|
March 24, 2017
Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis
Mathieu Uzzan, Julien Kirchgesner, Nadia Oubaya, et al.
Page
of 26